Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine
Abstract Aim Although opioids have been used as treatment of neuropathic pain, opioids have abuse potential in humans. Since soluble epoxide hydrolase (sEH) in the metabolism of polyunsaturated fatty acids plays a key role in the pain, sEH inhibitors would be promising new therapeutic drugs for neur...
Saved in:
Main Authors: | Xiayun Wan (Author), Yuko Fujita (Author), Lijia Chang (Author), Yan Wei (Author), Li Ma (Author), Gerile Wuyun (Author), Yaoyu Pu (Author), Bruce D. Hammock (Author), Kenji Hashimoto (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
by: Kenji Hashimoto
Published: (2019) -
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019) -
Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
by: Karen M. Wagner, et al.
Published: (2021) -
Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Published: (2020) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019)